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Objectives: To assess the effect of general practice characteristics and antibiotic 
prescribing on the number of non-susceptible E. coli isolated from urine specimens 
submitted from community settings, we undertook an ecological study of the general 
practice population in the West Midlands.  
  
Method: Descriptive analysis and multilevel modelling of temporal trends in antibiotic 
prescribing and non-susceptibility of E.coli urine isolates to a range of antibiotics 
prescribed in the community over a 4 year period.   
 
Results: Nine of the 16 antibiotic prescribing / non-susceptibility combinations 
demonstrated a significant statistical linear correlation with non-susceptibility either 
for prescribing in the quarter or for prescribing within the previous 12 months. The 
magnitude of the effect varied, from a 0.3% increase in non-susceptibility to 
ampicillin/amoxicillin (when prescribing ampicillin/amoxicillin) to a 6.3% increase in 
non-susceptibility to nitrofurantoin (when prescribing nitrofurantoin) for an increase of 
50 DDDs per 1000 practice population within a quarter (equivalent to approximately 
10 courses of antibiotics). In 15 of the 16 models, single-handed general practices 
were shown to have a significant association with increased numbers of non-
susceptible E. coli urine isolates (adjusted ORs 1.083 to1.606).  
Increased prescribing of ampicillin / amoxicillin in winter periods was associated with 
increased non-susceptibility of E. coli isolated from urine specimens.    
   
Conclusions: Small increases in antibiotic prescribing in individual general practices 
reduces the number of susceptible bacteria in the practice population. In order to 
 
 
maintain the effectiveness of available treatment, antibiotic stewardship should be 



























Antimicrobial resistance (AMR) is a considerable threat to public health and the use 
of antibiotics has been cited as the single most important factor leading to 
antimicrobial resistance. 1 In 2014 in the UK, 74% of antibiotic prescribing occurred 
in general practice 2. Antibiotic prescribing in the community is associated with the 
development of AMR: 3,4 however some community prescribers are sceptical that 
reduction in their antibiotic prescribing will reduce the levels of AMR in their practice 
population. 5 Other factors such as the practice location, length of appointment, 6 
social deprivation 7 and single-handed practices 8 have been shown to be  
associated with increased antibiotic prescribing in the UK.        
The Chief Medical Officer (CMO) for England in her 2011 annual report promoted the 
use of antibiotic stewardship as a measure to control the development and spread of 
AMR; 9 however a study in 2014 reported that  Public Health England (PHE) clinical 
prescribing guidance has not reduced prescribing in the community. 10 
 
Urinary tract infections (UTI), and in particular those caused by Escherichia coli, 
were the focus of this study because UTIs are one of the most common conditions 
diagnosed in community settings in Europe and are an important clinical indication of 
prescribing in primary care, 11 with E. coli being the commonest cause of UTIs in 
both primary and secondary care. 12  
 
A systematic review of studies reporting on the association between antibiotic 
prescribing and resistance reported that the inability to measure the time between 
prescribing and detection of resistance, control for practice / population 
 
 
characteristics or examine co-selection (use of one antibiotic leading to resistance in 
another antibiotic) has been a limiting factor when interpreting results. 3  
 
To address some of the gaps in previous studies, we undertook an ecological study 
to examine the relationship between prescribing antibiotics commonly used in 
general practice and non-susceptibility of E. coli isolates from urine samples taken in 





Setting / Population 
In 2012 there were 950 general practices with 3635 general practitioners serving a 
population of 5.8 million registered patients in the West Midlands Region. 13 During 
2010-2014, there were 15 diagnostic microbiology laboratories serving both 
community-based healthcare centres and hospitals.  
 
Data sources 
Antibiotic prescribing data on items dispensed in each general practice during the 
period 2010-2014   was obtained from NHS Digital (previously known as the Health 
and Social Care Information Centre). 14 Antibiotic prescribing data is expressed as 
defined daily doses (DDD) per 1000 general practice population.  
Data on antibiotic non-susceptibility for E. coli isolates from urine specimens 
submitted from general practices was obtained from the Public Health England 
(PHE) Second Generation Surveillance System (SGSS), previously known as the 
 
 
AmSurv system. 15 To detect emerging non-susceptibility, we de-duplicated the 
dataset by removing only duplicate E. coli reports from each patient having exactly 
matching antibiotic susceptibility results within the same year. Nine of the15 
laboratories were reporting data regularly to SGSS/AmSurv at the start of our study 
period in 2010, and complete coverage of all 15 laboratories was achieved in 2012.  
Non-susceptibility to an antibiotic was defined as test results with a ‘resistant’ (R) or 
‘intermediate’ (I) designation. The antibiotics included in the study are detailed in 
Table 1. 
 
Data on general practice characteristics was obtained from the National Health 
Service (NHS) Business Services Authority (http://www.nhsbsa.nhs.uk/). This 
included data on the total practice population, proportion of the practice population 
<15 years old and ≥ 65 years, and ratio of females to males in the practice 
population. The number of general practitioners (GPs) within each practice was 
obtained from NHS Digital, with single-handed practices defined as those practices 
with only one registered GP. 16  
 
We measured social-economic deprivation using data from the English Index of 
Multiple Deprivation 2010. 17 A deprivation index was assigned to each general 
practice based on the deprivation index assigned to the Local Authority (English 
administrative area) in which the practice was located.  
 
The general practices were categorised as ‘urban’ or ‘rural’ based on whether the 
majority of the population in the Local Authority in which the practice is situated live 




Seasons were defined as spring (March to May), summer (June to August), autumn 
(September to November), and winter (December to February). We calculated 
seasonal total DDD prescribing quantities and DDDs /1000 practice population for 
the period March 2010 to February 2014. These were compared with non-
susceptibility proportions for E. coli urinary isolates against the 6 antibiotics selected 
for analysis in order to describe prescribing and non-susceptibility trends during the 
study period.       
 
Statistical analysis 
 Sixteen separate datasets were created. Each dataset consisted of data on all 
reported E .coli isolates non-susceptible to one of the 6 selected antibiotics by 
practice, alongside matching practice prescribing data for the same antibiotic or 
another commonly prescribed antibiotic that may select non-susceptibility (Table 1).  
Antibiotic combinations were selected based on biological plausibility of an 
exposure/non-susceptibility relationship and to enable comparisons with other 
international studies.3 For each combination, seasonal quarterly trends in non-
susceptibility of E. coli isolates for each general practice from 01/03/2010 to 
28/02/2014 were compared to trends in antibiotic prescribing data in the same 
quarter and previous quarters (up to four lagged quarters).   
National community prescribing guidance recommends course lengths of between 3 
– 10 days depending on the antibiotic and the clinical presentation. 19 We therefore 
set a prescribing unit within the statistical models of 50 DDDs, which represents 
approximately 10 prescriptions, taking an average of 5 days for each course.  
 
 
General practice characteristics were included in the statistical models as potential 
explanatory variables (Table 2). 
 
Multilevel mixed-effects generalised linear models, using a binomial distribution for 
the outcome, were developed to examine the relationship between antibiotic use and 
E.coli non-susceptibility.  Each statistical model (one for each prescribing / non-
susceptibility combination) consisted of the number of E. coli isolates non-
susceptible by general practice as the outcome variable, number tested as the 
denominator, as well as the various explanatory variables, including antibiotic 
prescribing in the current and lagged prescribing quarters described above, which 
formed the fixed-effect portion of the models. A composite group variable was 
created using general practice and Local Authority area to form a 2nd level random 
intercept to allow modelling of variability between these hierarchical populations as 
random effects. Likelihood ratio testing was used to determine significance and a P 
value of ≤0.05 was considered statistically significant. Adjusted odd ratios were used 
as a measure of association.  
Cubic functions of all continuous variables explanatory variables were constructed 
and then subsequently tested for linearity via a stepwise iterative process.  
Significant non-linear variables were retained and tested to determine if they were 
still significant when inserted into the model together. When satisfied that any 
remaining non-linear terms were still significant when tested together in the model, 
the significance of the linear covariates were tested. All lagged prescribing quarters 
were included in each of the statistical models; however as prescribing data prior to 
2010 was not available, to increase the number of complete observations the 
DDD/1000 practice population variable with the greatest lag was removed if it was 
 
 
found to be not statistically significant, and was not a substantial confounder (i.e. its 
removal did not lead to a >10% change in the odds ratios of the linear variables). 
The model building process was then repeated with the increased number of 
comparable observations. 
All other explanatory variables were retained in a linear or non-linear form, 
depending on which form was found to best fit the data within each model (see 
supplementary data file).       
 




During the study period there were 313,085 E. coli reports from urine specimens 
submitted by West Midland GPs. These represented 247,971 de-duplicated 
laboratory reports of E. coli, from 181,764 patients, submitted by 911 of 948 (96%) 
general practices prescribing antibiotics in the West Midlands.  
 
The proportion of E.coli isolates tested against the selected antibiotics and the 
proportion reported as non-susceptible during the study period are shown in Table 3.  
Data from all 948 general practices that prescribed antibiotics in the West Midlands 
during the study period were included. The quantity of antibiotic prescribing varied 
widely across general practices. In 2013, the 5th and 95th percentile for total 
antibiotics prescribed by individual West Midland general practices was 4431 
DDD/1000 population and10076 DDD/1000 population. In 2013, a total of 45 million 
antibiotic DDDs were prescribed in the West Midlands. Amongst the antibiotics 
 
 
included in the study, ampicillin / amoxicillin was the most commonly prescribed in 
2013 with13.6 million DDDs, followed by co-amoxiclav with 2.9 million DDDs and 
trimethoprim 2.8 million DDDs.    
 
Fifteen percent (141/948) of general practices were single-handed (Table 2), and 
82% (116/141) of these were designated as being in rural locations. When 
comparing single-handed GPs as a group, the prescribing rate was consistently 
higher throughout the study period than the group consisting of non-single handed 
GP practices (Figure 1).  
 
Increased non-susceptibility to ampicillin/amoxicillin was observed in E. coli urine 
isolates in the winter periods which mirrored observed winter peaks in prescribing of 
ampicillin/amoxicillin (Figure 2). Seasonal changes in antibiotic prescribing and non-
susceptibility was not observed for other antibiotics included in the study.     
 
Nine of the sixteen multi-level mixed effects statistical models showed a statistically 
significant linear relationship between E.coli non-susceptibility and the prescription of 
defined antibiotics during the same seasonal quarter or prescribing within the 
previous 12 months. Three of the remaining models showed statistically significant 
non-linear relationships for some of the seasonal quarters, and 4 models had no 
statistical associations between the prescribed antibiotic and non-susceptibility 
(please see supplementary data for complete modelling results).       
Ampicillin/amoxicillin was the only antibiotic for which the odds of increased E.coli 
non-susceptibility was associated with an increase in prescribing within the same 
 
 
quarter, when prescribing ampicillin/amoxicillin and co-amoxiclav (OR 1.003, 95% CI 
1.001 - 1.006 and OR 1.006, 95% CI 1.002 - 1.009 respectively). 
There was also an association between prescribing in previous quarters, and 
increased non-susceptibility of E. coli to  co-amoxiclav (when prescribing 
ampicillin/amoxicillin), ciprofloxacin (when prescribing fluoroquinolones), 
nitrofurantoin (when prescribing cephalexin and nitrofurantoin) and trimethoprim 
(when prescribing trimethoprim) (Table 4). 
The magnitude of the statistical associations varied. In model 2, for every increase of 
50DDD per 1000 population of ampicillin within the same quarter we found an 
increase in the odds of ampicillin/amoxicillin non-susceptibility of 0.3% (95% CI 0.2% 
- 0.6%, p= 0.001). In model 14, for every increase of 50DDD per 1000 population of 
nitrofurantoin within the previous quarter we found an increase in the odds of 
nitrofurantoin non-susceptibility of 6.3% (95% CI 1.3% -11.5%, p= 0.013). 
 
There was a significant negative association in the same quarter with non-
susceptibility to: co-amoxiclav when prescribing ampicillin/amoxicillin, ciprofloxacin 
when prescribing co-amoxiclav, trimethoprim when prescribing trimethoprim and in 
the same quarter and in the previous 12 months for nitrofurantoin when prescribing 
nitrofurantoin (Table 4), indicating increased prescribing in those periods are 
associated with lower numbers of non-susceptible E. coli.         
 
A statistically significant positive association was found between E. coli non-
susceptibility and single-handed practices in all 16 prescribing / non-susceptibility 
statistical models (Table 5), with a single-handed practice associated with increased 





Our study showed that small increases in antibiotic prescribing by general practices 
in the West Midlands for a range of antibiotics increased the odds that E. coli UTI 
isolates from the practice population would be non-susceptible to one or more 
antibiotics.  
 
Although an ecological study across a large regional population, our findings of an 
association between ampicillin/amoxicillin non-susceptibility in E .coli and prescribing 
levels during the same time period are similar to those from patient-level studies in 
England in 2005 and Wales in 2007. 20,21. The Welsh study also supports our 
findings of no statistical association between ampicillin/amoxicillin non-susceptibility 
and prescribing of ampicillin/amoxicillin twelve months prior to the susceptibility tests. 
21  
 
A 2007 study of a large portion of the general practice population in Wales found a 
statistically significant decrease in ampicillin resistance of 1.03% for every decrease 
of 50 amoxicillin items dispensed per 1000 patients per annum and a decrease in 
trimethoprim resistance of 1.08% for every decrease of 20 trimethoprim items 
dispensed per 1000 patients per annum, 22  which supports our findings, only in the 
opposite direction as we measured the effect on non-susceptibility by small 
increases in antibiotic prescribing. 
The immediate effect described of increased E. coli non-susceptibility to 
ampicillin/amoxicillin with increased prescribing of beta-lactam antibiotics (Models 1 
and 2) may be due to the selection and rapid multiplication of TEM beta-lactamase 
 
 
producing strains 23 (Table 4). It is therefore plausible that the selection of these 
strains would have a negative association with co-amoxiclav, as observed in Model 
4, as this antibiotic remains active against common TEM beta-lactamases. The 
successful E. coli urinary pathogenic clonal group ST131 is associated with 
combined non-susceptibility to beta-lactam antibiotics and fluoroquinolones, 24 and 
therefore the successful action of co-amoxiclav against these strains may also 
reduce the population non-susceptible to ciprofloxacin, as observed in Model 5. The 
negative association with non-susceptibility to co-amoxiclav (prescribing 
ampicillin/amoxicillin) and trimethoprim (prescribing trimethoprim) in the immediate 
quarter is reversed in previous prescribing quarters with a positive association, 
suggesting sufficient time had elapsed for a previously susceptible population to 
acquire resistance.    
Nitrofurantoin remains active against multi-drug resistant (MDR) E.coli, which may 
explain the negative association with non-susceptibility and increased prescribing of 
nitrofurantoin in the same quarter. Non-susceptibility to nitrofurantoin is conferred by 
mutation, and we observe increased odds of non-susceptibility when prescribing 
nitrofurantoin in the previous quarter. A study from Sweden in 2013 25 suggests that 
the establishment of E. coli clones non-susceptible to nitrofurantoin is unlikely due to 
the severe fitness cost imposed by the required mutation. This may explain the 
negative association we observe in prescribing nitrofurantoin 12 months previously 
(Model 14).         
 
To our knowledge, this is the first study to show that single-handed practices are 
associated with higher levels of antibiotic non-susceptibility.  A systematic review 
measuring the effectiveness of single- handed practices suggested that the observed 
 
 
higher general prescribing rates by these practices may be due to higher workloads, 
shorter appointment times and the lack of opportunity to discuss prescribing 
protocols with colleagues. 26 Although we report that 15% of practices in the West 
Midlands were single-handed, there has been a move towards group practices in 
England; however in many parts of Europe single-handed practices still predominate. 
26  
 
We report an observed temporal relationship between prescribing 
ampicillin/amoxicillin and non-susceptibility to this antibiotic in E. coli urine isolates, 
with peaks in the winter months (Figure 2). In a study in the USA in 2012 similar 
seasonal relationships were demonstrated for a number of combinations of 
prescribed antibiotics and resistance, including a correlation of prescribing 
aminopenicillins (lagged by 1 month) and resistance in all E. coli isolates. 27 
Ampicillin/amoxicillin prescribing represented 30% of the total quantity of antibiotics 
prescribed in the West Midlands in 2013. In the UK, amoxicillin is not first-line 
treatment for UTI, but it is first-line treatment for many community respiratory 
infections. 19 It is therefore plausible that the winter peaks in prescribing for 
respiratory conditions is selecting non-susceptibility in urine isolates. A recent UK 
study found that most general practices over-prescribe for respiratory conditions. 28  
A randomised controlled trial in 2005 showed use of narrow spectrum antibiotics 
rather than amoxicillin resulted in comparable clinical outcomes among hospitalised 
patients with community-acquired pneumonia. 29 Our findings suggest this approach 




This is a retrospective ecological study and therefore is not able to draw inferences 
about individual risk of antimicrobial resistance. Significant statistical associations in 
these types of studies should be interpreted as only suggestive as they do not 
necessarily imply cause –effect relationships.  Whilst this is a limitation it was noted 
in a large review in 2013 of individual patient and ecological studies that antibiotic 
pressure at population level maybe more important in determining risk of harbouring 
resistant bacteria in the community. 3  
 
DDDs were chosen as the metric for antibiotic prescribing as they are the most 
commonly applied unit of measurement and are recognised internationally as a 
bench-marking measure. It also allowed comparison with international studies 
comparing prescribing with antibiotic resistance.  However it is recognised that DDDs 
do not always accurately reflect prescribing for children or persons with renal 
impairment. 
Multilevel modelling is a strength of this study as it allows random effects in the 
population to be taken into account whilst adjusting for a number of potential 
predictor or confounding variables. Following a review of the literature we found only 
a limited number of studies included practice characteristics and of these 
comparable interactions between these variables with either not found, 20  or were 
not reported. 6 A systematic approach of testing potential interactions was 
considered for our study; however this would have added over 30 pairwise 
combinations of variables. Therefore to ensure manageability and aide interpretation 
we chose to focus on the main effects of the various variables included in this study. 
We intend to examine potential interactions between practice characteristics in a 
future study.  
 
 
Seven of the 16 statistical drug/bug combination models developed did not show 
linear relationships between the prescribed antibiotic and non-susceptibility in E. coli 
urine isolates. Three of these models, however, did show significant non-linear 
associations between prescribing and non-susceptibility for some of the seasonal 
quarters, and this will also form part of the new study.   
Given the plausibility of bacteria carrying resistance genes to multiple antibiotics, 
there will be interdependence between some of the antibiotic combinations when 
measured against the same antibiotic non-susceptibility results. Therefore with the 
large amount of testing captured in this study we would expect to encounter a 
number of type one errors for particular antibiotic combinations. A more stringent 
significance test was considered; however this was not implemented due to the 
possibility of increasing the number of false negative associations.  
 
The antibiotic non-susceptibility data were extracted from routine laboratory reporting 
and therefore is subject to specimen selection bias as it is likely that urine samples 
sent for microbiological examination are from patients with treatment failures or 
those that have complicated and/or severe infections. 12  Notwithstanding this, it is 
encouraging that a study in Ireland in 2012 of urines taken from all adult patients 
suspected of having a UTI attending 22 practices found similar antibiotic 
susceptibility proportions. 30 We also found little variation in susceptibility proportions, 
reported in Table 3, between the de-duplicated data and all E. coli reports, providing 
confidence that this process was not inflating non-susceptibility in our modelling 
dataset. 
As we reported previously, there is variation in antibiotic susceptibility testing 
methods in West Midland laboratories12 and laboratories varied slightly in the 
 
 
antibiotics selected for first-line testing (Table 3). During this period 13 of the 15 
laboratories applied the most recent BSAC or EUCAST MIC breakpoint standards 
and all laboratories participated in monthly internationally accredited external quality 
control assessment of susceptibility testing methods 31.     
The West Midlands was the first region of England to implement routine AMR 
surveillance reporting and achieve complete reporting from local laboratories. 15 Not 
all laboratories were reporting at the beginning of the study in 2010, however a 
comparison of the overall antibiotic susceptibility data from the 9 laboratories 
reporting throughout the study period showed little variation with susceptibility data 
from all 15 laboratories. Multilevel mixed effects generalised linear models do allow 
for missing data; however, although the missing laboratories consisted of a cross-
section of laboratory sizes situated in both urban and rural localities, we accept that 
the missing AMR data in the first period of the study may bias the data.  
 
This large AMR dataset, for the first time, provides an opportunity to analyse the 
association between prescribing and resistance in a large English regional 
population. We are beginning to receive patient level prescribing data from the 
community and therefore we now have the opportunity to build on this study by 
further exploring the relationship between prescribing and antibiotic resistance.         
 
In summary our statistical models suggest that small increases in antibiotic 
prescribing within a general practice increases the number of non-susceptible 
bacteria isolated in urine samples within the practice population. We have shown 
that the large volumes of antibiotics likely to have been used in the treatment of 
respiratory conditions in winter months, appears to have an immediate short-term 
 
 
effect of increased antibiotic non-susceptibility in bacteria causing unrelated 
infections. Prudent prescribing, in line with Royal College of General Practitioners 
guidance (http://www.rcgp.org.uk/clinical-and-research/toolkits/target-antibiotics-
toolkit.aspx) is required by individual general practices, particularly in winter periods, 
to maintain a population of susceptible bacteria in their local population, thereby 
preserving the effectiveness of available antibiotics. We have also shown that a 
single-handed GP practices may require additional antibiotic stewardship support 
and guidance.       
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Table 1: Antibiotic combinations evaluated to measure commonly associated resistance 
mechanisms found in E. coli and enable comparison with international studies  




Ampicillin / amoxicillin ampicillin/amoxicillin 2 
co-amoxiclav 1 
fluoroquinolones 3 
Cephalexin cephalosporins  10 
fluoroquinolones 11 
trimethoprim 16 
nitrofurantoin  12 
Co-amoxiclav co-amoxiclav 9 
ampicillin/amoxicillin 4 




Trimethoprim trimethoprim 15 
Nitrofurantoin nitrofurantoin  14 
















Table 2. Explanatory variables included in the multi-level mixed effects statistical model   
General Practice characteristics  West Midlands 
mean or %       
(if applicable) 
General practice list size 6252 
Registered patient gender ratio (female/male) 0.98 
Proportion of registered patients aged under age 15 years 18.21% 
Proportion of registered patients aged 65 years and over 16.15% 
Practices with one registered GP 15% 
Number of registered patients per GP 1700.31 
Location deprivation index (IMD2010) 28.14 
Rural practice location 27% 
  
Time variables   
Seasonal quarter 
(March-May, June-August, September-November, December - February) 
  

















Table 3. Percentage of antibiotic tests and non-susceptibility, March 2010 – November 2013. 
 




Ciprofloxacin 77.2 11.8 
Co-amoxiclav 88 18.2 
Cephalexin 83.4 6.9 
Ampicillin/Amoxicillin 85.1 52.1 
Nitrofurantoin 99.8 2.7 













Figure 1 Seasonal trends in total antibiotic prescribing rates by practices with a single general practitioner (GP) and those with multiple GPs 
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Winter months Non-susceptible DDD
 
 
Table 4. Adjusted significant linear associations between antibiotic prescribing and non-susceptibility in E. coli, by current (0) or lagged 
(negative) quarter   
Model 
no. 







1 ampicillin / amoxicillin co-amoxiclav Quarter 0 1.006 1.002 1.009 0.003 
2 ampicillin / amoxicillin ampicillin / amoxicillin Quarter 0 1.003 1.001 1.006 0.001 
4 co-amoxiclav ampicillin / amoxicillin Quarter 0 0.994 0.991 0.998 0.003 
Quarter -3 1.006 1.002 1.009 0.004 
Quarter -4 1.006 1.002 1.009 0.002 
5 ciprofloxacin co-amoxiclav Quarter 0 0.986 0.975 0.997 0.015 
8 ciprofloxacin fluoroquinolones Quarter -4 1.033 1.003 1.066 0.034 
9 co-amoxiclav co-amoxiclav Quarter -3 1.017 1.009 1.026 <0.001 
13 nitrofurantoin cephalexin Quarter -3 1.041 1.009 1.075 0.013 
14 nitrofurantoin nitrofurantoin Quarter 0 0.955 0.914 0.997 0.036 
Quarter -1 1.063 1.013 1.115 0.013 
Quarter -4 0.791 0.703 0.890 <0.001 
15 trimethoprim trimethoprim Quarter 0 0.988 0.978 0.999 0.031 
Quarter -1 1.016 1.004 1.028 0.008 
Quarter -2 1.018 1.006 1.030 0.003 





Table 5. Adjusted odds ratio (OR) between single GP practices and antibiotic non-














1 ampicillin / amoxicillin co-amoxiclav 1.097 1.027 1.171 0.006 
2 ampicillin / amoxicillin ampicillin / amoxicillin 1.083 1.014 1.156 0.018 
3 ampicillin / amoxicillin fluoroquinolones 1.095 1.024 1.170 0.008 
4 co-amoxiclav ampicillin / amoxicillin 1.361 1.148 1.614 <0.001 
5 ciprofloxacin co-amoxiclav 1.458 1.267 1.676 <0.001 
6 ciprofloxacin ampicillin / amoxicillin 1.448 1.258 1.666 <0.001 
7 ciprofloxacin cephalexin 1.370 1.180 1.592 <0.001 
8 ciprofloxacin fluoroquinolones 1.371 1.182 1.590 <0.001 
9 co-amoxiclav co-amoxiclav 1.398 1.171 1.669 <0.001 
10 cephalexin cephalosporin 1.528 1.322 1.767 <0.001 
11 cephalexin fluoroquinolones 1.534 1.337 1.759 <0.001 
12 cephalexin nitrofurantoin 1.534 1.340 1.756 <0.001 
13 nitrofurantoin cephalexin 1.606 1.304 1.979 <0.001 
14 nitrofurantoin nitrofurantoin 1.657 1.352 2.031 <0.001 
15 trimethoprim trimethoprim 1.110 1.026 1.201 0.009 
16 cephalexin trimethoprim 1.603 1.395 1.841 <0.001 
 
 
 
 
 
 
 
 
 
 
